ArticleThe New England journal of medicine2019
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.
Kirsten Fischer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
434 papers cite itlatest 60 shown
this paperpooled ittrialcites it